Science Explorer Interactive view Map
Company · Cahors · France

Groupe Cahors (France)

groupe-cahors.com/fr-france?country=frROR OpenAlex
Research works
63
▲ 43% vs 2013–17
Citations
446
7.1 per fractional work
Top-10% rate
2.7%
record average 16.5%
Open access
18%
world 28%

Not ranked overall: Groupe Cahors (France) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.91× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 1.84× its world share, 1 worksBiochemistry, Geneti…Immunology and Microbiology: 6.84× its world share, 1 worksImmunology and Micro…Neuroscience: 1.95× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 0.67× its world share, 0 worksPharmacology, Toxico…Engineering: 0.11× its world share, 0 worksEngineeringPhysics and Astronomy: 0.69× its world share, 0 worksPhysics and AstronomyHealth Professions: 3.46× its world share, 1 worksHealth ProfessionsMedicine: 2.44× its world share, 5 worksMedicineArts and Humanities: 0.35× its world share, 0 worksArts and HumanitiesEconomics, Econometrics and Finance: 4.30× its world share, 1 worksEconomics, Econometr…Social Sciences: 0.48× its world share, 1 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 6.8×. Every wedge is a field page.

Which keywords describe research at Groupe Cahors (France)?

By fractional works in all years, weighted toward what it does more of than the world: Epidemiology, Public Health, Diagnosis, Primary Care, Treatment, Social Determinants of Health, Healthcare Quality Indicators and Healthcare Policy.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Epidemiology11▲ 4.3×47 topics
  2. Public Health6▲ 7.2×9 topics
  3. Treatment4▲ 5.4×17 topics
  4. Diagnosis4▲ 6.6×19 topics
  5. Primary Care4▲ 14×3 topics
  6. Social Determinants of Health4▲ 25×2 topics
  7. Healthcare Policy4▲ 74×1 topic
  8. Healthcare Quality Indicators4▲ 98×2 topics
  9. Inequalities4▲ 151×1 topic
  10. Pathogenesis3▲ 8.0×12 topics
  11. Risk Factors3▲ 4.2×8 topics
  12. Inflammation3▲ 1.84×15 topics
  13. Complications3▲ 7.9×9 topics
  14. Cardiovascular Disease2▲ 3.3×13 topics
  15. Quality of Life2▲ 2.7×16 topics
  16. Virulence Factors2▲ 16×6 topics
  17. Bacteremia2▲ 35×3 topics
  18. Rituximab2▲ 17×3 topics
  19. Genetic Mutations2▲ 5.0×9 topics
  20. Surgery2▲ 7.8×6 topics
  21. Autoantibodies2▲ 10×5 topics
  22. Global Burden2▲ 4.4×4 topics
  23. Lymphoma2▲ 16×3 topics
  24. Surgical Management2▲ 5.4×5 topics
  25. Clinical Guidelines1▲ 7.2×3 topics
  26. Clinical Practice Guidelines1▲ 4.1×9 topics
  27. Prevention1▲ 5.7×8 topics
  28. Prophylaxis1▲ 16×3 topics
  29. Cardiovascular Risk1▲ 5.7×3 topics
  30. Genetic Variants1▲ 9.3×3 topics
  31. Rehabilitation1▲ 5.7×5 topics
  32. Smart Grids1▲ 62×2 topics
  33. Endocarditis Guidelines1▲ 52×1 topic
  34. Infective Endocarditis1▲ 52×1 topic
  35. Juvenile Idiopathic Arthritis1▲ 38×2 topics
  36. Antihypertensive Drugs1▲ 31×1 topic
  37. Blood Pressure1▲ 24×1 topic
  38. Genetic Pathogenesis1▲ 28×1 topic
  39. Host-Pathogen Interactions1▲ 17×3 topics
  40. Molecular Profiling1▲ 14×1 topic

Which research topics does Groupe Cahors (France) publish most on?

By volume in 2022–2025: Pharmaceutical Economics and Policy, Lymphoma Diagnosis and Treatment, Chronic Lymphocytic Leukemia Research and Autoimmune and Inflammatory Disorders Research.

Pharmaceutical Economics…1Pharmaceutical Economics and Policy: 1 fractional worksLymphoma Diagnosis and Treatment: 1 fractional worksChronic Lymphocytic Leukemia Research: 0 fractional worksAutoimmune and Inflammatory Disorders Research: 0 fractional worksHealthcare Systems and Practices: 0 fractional worksT-cell and Retrovirus Studies: 0 fractional worksMigration, Identity, and Health: 0 fractional worksAdvanced Breast Cancer Therapies: 0 fractional worksVascular Tumors and Angiosarcomas: 0 fractional worksMulticulturalism, Politics, Migration, Gender: 0 fractional works
Economics and EconometricsPathology and Forensic MedicineGeneticsHematology6 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Pharmaceutical Economics and Policy Economics and Econometrics 1 works
  2. 2 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 1 works
  3. 3 Chronic Lymphocytic Leukemia Research Genetics 0 works
  4. 4 Autoimmune and Inflammatory Disorders Research Hematology 0 works
  5. 5 Healthcare Systems and Practices General Health Professions 0 works
  6. 6 T-cell and Retrovirus Studies Immunology 0 works
  7. 7 Migration, Identity, and Health Sociology and Political Science 0 works
  8. 8 Advanced Breast Cancer Therapies Pulmonary and Respiratory Medicine 0 works
  9. 9 Vascular Tumors and Angiosarcomas Oncology 0 works
  10. 10 Multiculturalism, Politics, Migration, Gender Political Science and International Relations 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available17.5%not open82.5%

World: 28% of research is openly available.

with international co-authors12.6%domestic only87.4%

World: 19% is written across borders.

How has Groupe Cahors (France)'s research output changed?

Output in 2018–2022 was 43% higher than in 2013–2017.

199520002005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.